The efficacy of molecular targeted therapy for unresectable hepatocellular carcinoma

The efficacy of molecular targeted therapy for unresectable hepatocellular carcinoma - The efficacy of molecular targeted therapy for liver cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035136

Enrollment

150

Registered

2018-12-04

Start date

2018-12-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases that the molecular targeting drug was induced according to the eligibility criteria of each medicine.

Exclusion criteria

Exclusion criteria: Cases which treatment was not consistent with a clinical guideline. Cases hard to be followed up. Cases the attending physician judges inappropriate as a subject of the current study.

Design outcomes

Primary

Measure	Time frame
Overall suruvival	—

Countries

Japan

Contacts

Public ContactAtsushi Takai

Kyoto University Department of Gastroenterology and Hepatology

atsushit@kuhp.kyoto-u.ac.jp075(751)4319

Outcome results